Skip to content

Clinical trials

Observational Multiple Sclerosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Observational Country / region: United States Clear all

296 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20033
20045
20053
20069
200710
20088
20095
201011
201113
201216
201317
201417
201512
20168
201714
201811
201916
202019
202129
202211
202317
202414
20259
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed178
Recruiting40
Terminated22
Unknown status20
Active, not recruiting13
Withdrawn12
Enrolling by invitation6
Suspended3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen25
Novartis Pharmaceuticals19
National Institute of Neurological Disorders and Stroke (NINDS)11
University at Buffalo10
NYU Langone Health7
Brigham and Women's Hospital6
EMD Serono6
Providence Health & Services5
University of California, San Francisco5
University of Southern California5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis296
Multiple Sclerosis, Relapsing-Remitting28
Parkinson Disease16
Amyotrophic Lateral Sclerosis12
Crohn Disease10
Multiple Sclerosis, Chronic Progressive10
Spinal Cord Injuries10
Alzheimer Disease9
Psoriasis9
Stroke9

Trials

Showing 1 to 25 of 296. Each trial links to its page on Pharma Observatory.

196 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.